Antiplatelet Drugs Market
- 2026 年市場規模
- USD 2,907 Mn
- 2033 年預估規模
- USD 4,920 Mn
- 年複合成長率 CAGR
- 7.83%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Antiplatelet Drugs Market, By Drug Class (Irreversible Cyclooxygenase (COX) Inhibitors, Adenosine Diphosphate (ADP) Receptor Inhibitors, Glycoprotein IIB/IIIA Inhibitors, Adenosine Reuptake Inhibitors, Thromboxane Inhibitors and Phosphodiesterase Inhibitors), By Mode of Administration (Oral, Intravenous), By Application (Angioplasty, Arterial Thrombosis, Myocardial Infarction, Percutaneous Coronary Interventions, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Antiplatelet drugs are prescribed to individuals with a history of heart attacks and these drugs aid in reducing reoccurrence of heart attacks. Some of the antiplatelet medications include, aspirin, clopidogrel, prasugrel, and ticagrelor. Aspirin is recommended for all patients with Acute Coronary Syndrome (ACS), in the absence of hypersensitivity. It is prescribed along with one of the oral antiplatelet agents including Clopidogrel, Prasugrel, and Ticagrelor. Prasugrel is prescribed for patients suffering from ACS and for those undergoing Percutaneous Coronary Intervention (PCI). Clopidogrel and Ticagrelor aid in preventing atherothrombotic events in adult patients with ACS, and those who are treated with Coronary Artery Bypass Grafting (CABG) or PCI.
Market Dynamics
Increasing incidence of chronic diseases such as obesity, diabetes, and cardiovascular diseases (CVDs) is increasing the risk of heart attacks, which in turn is propelling demand for antiplatelet drugs. For instance, according to American Diabetes Association, in 2019, 37.3 million U.S. citizens or 11.3% of the population, had diabetes. Of the 37.3 million adults, nearly 1.9 million U.S. citizens had type 1 diabetes, including about 244,000 children and adolescents. Of the 37.3 million adults with diabetes, 28.7 million were diagnosed, and 8.5 million were undiagnosed. In 2019, 96 million U.S. citizens age 18 and older had prediabetes. 1.4 million U.S. citizens are diagnosed with diabetes every year. According to report by Centers for Disease Control and Prevention, heart disease cost the U.S. about US$229 billion each year from 2017 to 2018. This included the cost of health care services, medicines, and lost productivity due to death. In the U.S. according to the Center for disease control, about 20.1 million adults age 20 and older had Coronary Artery Disease in the year 2019.
Key features of the study
• This report provides an in-depth analysis of the global antiplatelet drugs market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global antiplatelet drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AstraZeneca Plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., Eli Lilly and Company, Merck & Co., Inc., Otsuka Pharmaceutical Company, Ltd., Sanofi, and The Medicines Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global antiplatelet drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antiplatelet drugs market
Market Segmentation
• Drug Class Insights (Revenue, USD Mn, 2026 - 2033)
o Irreversible Cyclooxygenase (COX) Inhibitors
o Adenosine Diphosphate (ADP) Receptor Inhibitors
o Glycoprotein IIB/IIIA Inhibitors
o Adenosine Reuptake Inhibitors
o Thromboxane Inhibitors and Phosphodiesterase Inhibitors
• Mode of Administration Insights (Revenue, USD Mn, 2026 - 2033)
o Oral
o Intravenous
• Application Insights (Revenue, USD Mn, 2026 - 2033)
o Angioplasty
o Arterial Thrombosis
o Myocardial Infarction
o Percutaneous Coronary Interventions
o Others
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o AstraZeneca Plc
o Boehringer Ingelheim GmbH
o Bristol-Myers Squibb Company
o Daiichi Sankyo, Inc.
o Eli Lilly and Company
o Merck & Co., Inc.
o Otsuka Pharmaceutical Company, Ltd.
o Sanofi
o The Medicines Company
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Mode of Administration
Market Snapshot, By Application
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Recent Developments
o Acquisitions and Partnerships Scenario
o Technology Overview
o Regulatory Scenario
o Pricing Analysis
o Epidemiology Analysis
o PORTER’S Five Forces
4. Global Antiplatelet Drugs Market, By Drug Class, 2026 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Irreversible Cyclooxygenase (COX) Inhibitors
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Adenosine Diphosphate (ADP) Receptor Inhibitors
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Glycoprotein IIB/IIIA Inhibitors
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Adenosine Reuptake Inhibitors
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Thromboxane Inhibitors and Phosphodiesterase Inhibitors
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
5. Global Antiplatelet Drugs Market, By Mode of Administration, 2026 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Oral
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Intravenous
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
6. Global Antiplatelet Drugs Market, By Application, 2026 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Angioplasty
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Arterial Thrombosis
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Myocardial Infarction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Percutaneous Coronary Interventions
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Others
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
7. Global Antiplatelet Drugs Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
o North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Mode of Administration, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Mode of Administration, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Mode of Administration, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Mode of Administration, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Mode of Administration, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Mode of Administration, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
AstraZeneca Plc
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Boehringer Ingelheim GmbH
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Bristol-Myers Squibb Company
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Daiichi Sankyo, Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Eli Lilly and Company
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Merck & Co., Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Otsuka Pharmaceutical Company, Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Sanofi
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
The Medicines Company
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
9. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們